Injury Lawyer Blog
In July of 2012 Stryker Orthopedics announced a recall of its Stryker Rejuvenate and Stryker ABG II hip implant products. The announcement came as a result of a gradual wearing away and corrosion of the company’s Stryker Rejuvenate and ABGII hip replacement products that caused tissue damage, metallosis, and necrosis. Fortunately enough the patients implanted with the defective medical devices will be compensated now that plaintiff attorneys and Styker have reached a settlement agreement.
The settlement agreement reached on November 3, 2014, and executed in New Jersey, provides compensation for nearly 3,000 injured patients. The settlements took nearly four months to negotiate, and was overseen by New Jersey Superior Court Judge Brian R. Martinotti of Bergen County.
The settlement agreement will likely reach more than $1 billion dollars with nearly $300,000 awarded for each defective implant. Much to Stryker’s dismay, liabilities are not capped, and patients in need of additional surgery but unable to qualify due to medical reasons will receive an additional one-time compensation.
For the Patient:
The settlement is exclusively for patients who were implanted with ABG II Modular or Rejuvenate Modular hip in the United States and subsequently underwent revision surgery within 181 days of the initial implant and prior to November 3, 2014. Patients interested in joining the settlement offer must submit their claim by December 14, 2014.